1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits for the Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Process
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Supplier
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. ACUTE KIDNEY INJURY DISEASE TREATMENT MARKET BY COMPONENT
5.1. Introduction
5.2. Treatment
5.2.1. Drug Type
5.2.1.1. Isotonic Solution
5.2.1.2. Antibiotic
5.2.1.3. Others
5.2.2. Dialysis
5.3. Diagnosis
5.3.1. Urine Test
5.3.2. Blood Test
5.3.3. Glomerular Filtration Rate (GFR)
5.3.4. Imaging Test
5.3.5. Biopsy
6. ACUTE KIDNEY INJURY DISEASE TREATMENT MARKET BY TYPE OF RRT
6.1. Introduction
6.2. Continuous
6.3. Intermittent
7. ACUTE KIDNEY INJURY DISEASE TREATMENT MARKET BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. By Component
7.2.2. By Type of RRT
7.2.3. By Country
7.2.3.1. USA
7.2.3.2. Canada
7.2.3.3. Mexico
7.3. South America
7.3.1. By Component
7.3.2. By Type of RRT
7.3.3. By Country
7.3.3.1. Brazil
7.3.3.2. Argentina
7.3.3.3. Others
7.4. Europe
7.4.1. By Component
7.4.2. By Type of RRT
7.4.3. By Country
7.4.3.1. Germany
7.4.3.2. France
7.4.3.3. United Kingdom
7.4.3.4. Spain
7.4.3.5. Others
7.5. Middle East and Africa
7.5.1. By Component
7.5.2. By Type of RRT
7.5.3. By Country
7.5.3.1. Saudi Arabia
7.5.3.2. UAE
7.5.3.3. Israel
7.5.3.4. Others
7.6. Asia Pacific
7.6.1. By Component
7.6.2. By Type of RRT
7.6.3. By Country
7.6.3.1. China
7.6.3.2. Japan
7.6.3.3. South Korea
7.6.3.4. India
7.6.3.5. Others
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. Exponential Biotherapies, Inc.
9.2. Nikkiso America, Inc.
9.3. Am-Pharma
9.4. Renalguard Solutions, Inc.
9.5. Angion Biomedica Corp.
9.6. Thrasos Therapeutics Inc.
9.7. Atoxbio
9.8. Sentien Biotechnologies, Inc